The global retinitis pigmentosa market, valued at $11.31 billion in 2024, is expected to grow to $25.87 billion by 2034, driven by gene therapy advancements, aging populations, and strategic ...

Research published 30 years ago made a connection between HSV-1 and Alzheimer's disease. Doctors weigh in on how relevant (or not) it remains.

The cold sore-causing Herpes Simplex Virus (HSV-1) hijacks human cells and reconfigures its DNA within just an hour after infection, according to a new study that may help tackle the pathogen.

They enrolled 82 men and women who had been diagnosed with their first episode of genital HSV-1 infection. Fifty-four (66%) were women and 28 (34%) were men.

Other recent entrants come from the mRNA field, with Moderna having fully enrolled its 300-person phase 1/2 U.S. trial of its candidate, mRNA-1608, in herpes simplex virus type 2 (HSV-2) this year ...

Medical researchers found a new way genetics influences the body's antiviral response by studying a life-threatening disease caused by a common virus: herpes simplex virus 1 (HSV-1).

SALT LAKE CITY — In this Healio Video Perspective from the ARVO meeting, SriniVas R. Sadda, MD, FARVO, discusses a long-term study evaluating MCO-010 for the treatment of retinitis pigmentosa.